Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mark Gelfand
AddedMar 31, 2024
UpdatedMay 31, 2026
Mark Gelfand

Mark Gelfand

Co-Founder, Soffio Medical

CrunchbaseLinkedIn

Mark Gelfand's Career

Soffio Medical
Soffio Medical

Boston, MA, US

Co-Founder
Axon Therapies
Axon Therapies

New York City, NY, US

Co-Founder
Coridea
Coridea

New York City, NY, US

Co-Founder
CorVent Medical
CorVent Medical

Fargo, ND, US

Board Member· Board
Cibiem
Cibiem

Los Altos, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mark Gelfand's Career

Soffio Medical
Soffio Medical
Series A$3M62015Boston, MA, US
Co-Founder

Leadership at Soffio Medical

Aaron SandoskiAaron SandoskiBoard Member

Similar to Soffio Medical

Invent MedicalInvent MedicalCarlsbad, CA, USMedical Devicesest. 2014Invent MedicalCarlsbad, CA, US · est. 2014

Invent Respiratory: Developing advanced respiratory care devices for patient recovery and rehabilitation.

Seed · $258.1k6
Aero TherapeuticsAero TherapeuticsSan Diego, CA, USMedical Devicesest. 2019Aero TherapeuticsSan Diego, CA, US · est. 2019

Aero Therapeutics: Developing respiratory aid devices for low-resource settings.

Seed · $180k6
Portela Soni MedicalPortela Soni MedicalBoston, MA, USMedical Devicesest. 2014Portela Soni MedicalBoston, MA, US · est. 2014

Portela Soni Medical: Innovating patient care with our problem-solving catheter device.

Seed · $400k5
Axon Therapies
Axon Therapies

New York City, NY, US

Co-Founder
Coridea
Coridea

New York City, NY, US

Co-Founder
CorVent Medical
CorVent Medical
Seed$4.5M342020Fargo, ND, US
Board Member· Board

Leadership at CorVent Medical

Zoar EngelmanZoar EngelmanFounder
Richard S. WalshRichard S. WalshCEO
Cibiem
Cibiem
Acquired$13M02010Los Altos, CA, US
Co-Founder

Leadership at Cibiem

Neil ExterNeil ExterBoard Member
Paul LaviolettePaul LavioletteBoard Member
Howard LevinHoward LevinCo-Founder
Hank KuchemanHank KuchemanBoard Member
Ken MartinKen MartinCEO

Similar to Cibiem

NeuroBionicsNeuroBionicsSeattle, WA, USMedical DevicesNeuroBionicsSeattle, WA, US

Developing medical devices for neurological disorders.

Series A · $6M6
ClarimedixClarimedixBoulder, CO, USMedical Devicesest. 2006ClarimedixBoulder, CO, US · est. 2006

Clarimedix, Inc., a US-based medical device company, specializes in treating vascular dysfunction.

Angel · $275k5

Mark Gelfand's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Mark Gelfand

Mark AllenMark AllenCo-Founder · FutureProof TechnologiesAjay RamachandranAjay RamachandranFounder · Happiness VenturesAli DibaAli DibaCo-Founder · SensifaiGlenn LukGlenn LukCo-Founder · Healthcare.comAlex RandAlex RandFounder · Nextera Robotics